BridgeBio Pharma, Inc. (BBIO) vs Bio-Techne Corporation (TECH)
A side-by-side comparison of BridgeBio Pharma, Inc. and Bio-Techne Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBIO
BridgeBio Pharma, Inc.
$66.14HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
TECH
Bio-Techne Corporation
$72.58HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BBIO vs TECH
growth of $100 · dividends reinvested · last 7yBBIO +140.1% (+13.3%/yr)TECH +47.7% (+5.7%/yr)BBIO compounded faster over this window
BBIO TECH
BBIO vs TECH: by the numbers
- •BBIO is the larger company ($12.95B vs $11.36B market cap).
- •TECH is profitable (14.97% net margin) while BBIO runs a net loss (-97.64%).
- •BBIO grew revenue faster over the past five years (62.61% vs 5.47% CAGR).
- •TECH pays a dividend (0.55% yield), while BBIO has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BBIO | TECH |
|---|---|---|
| P/E ratio | N/A | 62.57 |
| Forward P/E | N/A | 35.48 |
| PEG ratio | N/A | 10.57 |
| P/S ratio | 18.17 | 9.35 |
| P/B ratio | N/A | 5.39 |
| EV / EBITDA | N/A | 32.61 |
| FCF yield | N/A | 2.32% |
Profitability
| Metric | BBIO | TECH |
|---|---|---|
| Gross margin | 93.35% | 65.77% |
| Operating margin | -113.35% | 20.73% |
| Net margin | -97.64% | 14.97% |
| ROE | N/A | 8.63% |
| ROIC | -62.14% | 7.86% |
Dividends
| Metric | BBIO | TECH |
|---|---|---|
| Dividend yield | N/A | 0.55% |
| Payout ratio | N/A | 34.48% |
Growth (annualized)
| Metric | BBIO | TECH |
|---|---|---|
| Revenue CAGR (5Y) | 62.61% | 5.47% |
| EPS CAGR (5Y) | N/A | 5.16% |
| FCF CAGR (5Y) | N/A | -3.08% |
| Total return CAGR (5Y) | 7.38% | -9.26% |
Frequently asked
- Which has grown faster, BBIO or TECH?
- Over the past five years, BBIO grew revenue faster — BBIO at a 62.61% CAGR versus TECH at 5.47%.
- Does BBIO or TECH pay a bigger dividend?
- TECH pays a dividend (0.55% yield), while BBIO has no payments in the available dividend history.
- Is BBIO or TECH more profitable?
- TECH runs the higher net margin — BBIO at -97.64% versus TECH at 14.97%.
- How have BBIO and TECH total returns compared?
- Over the past 5 years, BBIO delivered 7.38% and TECH delivered -9.26% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bio-Techne P/E ratioBio-Techne dividend yieldBridgeBio Pharma ROEBio-Techne ROEBridgeBio Pharma operating marginBio-Techne operating marginBridgeBio Pharma revenue growthBio-Techne revenue growthBridgeBio Pharma free cash flowBio-Techne free cash flow
BridgeBio Pharma & Bio-Techne appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.